These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 27878990)

  • 1. Hemodynamic-guided heart-failure management using a wireless implantable sensor: Infrastructure, methods, and results in a community heart failure disease-management program.
    Jermyn R; Alam A; Kvasic J; Saeed O; Jorde U
    Clin Cardiol; 2017 Mar; 40(3):170-176. PubMed ID: 27878990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
    Lindenfeld J; Zile MR; Desai AS; Bhatt K; Ducharme A; Horstmanshof D; Krim SR; Maisel A; Mehra MR; Paul S; Sears SF; Sauer AJ; Smart F; Zughaib M; Castaneda P; Kelly J; Johnson N; Sood P; Ginn G; Henderson J; Adamson PB; Costanzo MR
    Lancet; 2021 Sep; 398(10304):991-1001. PubMed ID: 34461042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction.
    Adamson PB; Abraham WT; Bourge RC; Costanzo MR; Hasan A; Yadav C; Henderson J; Cowart P; Stevenson LW
    Circ Heart Fail; 2014 Nov; 7(6):935-44. PubMed ID: 25286913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.
    Abraham WT; Adamson PB; Bourge RC; Aaron MF; Costanzo MR; Stevenson LW; Strickland W; Neelagaru S; Raval N; Krueger S; Weiner S; Shavelle D; Jeffries B; Yadav JS;
    Lancet; 2011 Feb; 377(9766):658-66. PubMed ID: 21315441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
    Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
    J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study.
    Shavelle DM; Desai AS; Abraham WT; Bourge RC; Raval N; Rathman LD; Heywood JT; Jermyn RA; Pelzel J; Jonsson OT; Costanzo MR; Henderson JD; Brett ME; Adamson PB; Stevenson LW;
    Circ Heart Fail; 2020 Aug; 13(8):e006863. PubMed ID: 32757642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Ambulatory Hemodynamic Monitoring of Heart Failure With Clinical Outcomes in a Concurrent Matched Cohort Analysis.
    Abraham J; Bharmi R; Jonsson O; Oliveira GH; Artis A; Valika A; Capodilupo R; Adamson PB; Roberts G; Dalal N; Desai AS; Benza RL
    JAMA Cardiol; 2019 Jun; 4(6):556-563. PubMed ID: 31090869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction.
    Lindenfeld J; Costanzo MR; Zile MR; Ducharme A; Troughton R; Maisel A; Mehra MR; Paul S; Sears SF; Smart F; Johnson N; Henderson J; Adamson PB; Desai AS; Abraham WT;
    J Am Coll Cardiol; 2024 Feb; 83(6):682-694. PubMed ID: 38325994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary experience with the multisensor HeartLogic algorithm for heart failure monitoring: a retrospective case series report.
    Capucci A; Santini L; Favale S; Pecora D; Petracci B; Calò L; Molon G; Cipolletta L; Bianchi V; Schirripa V; Santobuono VE; La Greca C; Campari M; Valsecchi S; Ammirati F; D'Onofrio A
    ESC Heart Fail; 2019 Apr; 6(2):308-318. PubMed ID: 30632306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable Hemodynamic Monitoring for Heart Failure Patients.
    Abraham WT; Perl L
    J Am Coll Cardiol; 2017 Jul; 70(3):389-398. PubMed ID: 28705321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CardioMEMS system in the clinical management of end-stage heart failure patients: three case reports.
    Tschöpe C; Alogna A; Spillmann F; Faragli A; Schmidt G; Blaschke F; Kühl U; Hertel E; Willner M; Morris D; Post H; Noutsias M; Pieske B; Krackhardt F
    BMC Cardiovasc Disord; 2018 Jul; 18(1):155. PubMed ID: 30064356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory Hemodynamic Monitoring Reduces Heart Failure Hospitalizations in "Real-World" Clinical Practice.
    Desai AS; Bhimaraj A; Bharmi R; Jermyn R; Bhatt K; Shavelle D; Redfield MM; Hull R; Pelzel J; Davis K; Dalal N; Adamson PB; Heywood JT
    J Am Coll Cardiol; 2017 May; 69(19):2357-2365. PubMed ID: 28330751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remote Hemodynamic-Guided Therapy of Patients With Recurrent Heart Failure Following Cardiac Resynchronization Therapy.
    Varma N; Bourge RC; Stevenson LW; Costanzo MR; Shavelle D; Adamson PB; Ginn G; Henderson J; Abraham WT;
    J Am Heart Assoc; 2021 Feb; 10(5):e017619. PubMed ID: 33626889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF).
    Angermann CE; Assmus B; Anker SD; Brachmann J; Ertl G; Köhler F; Rosenkranz S; Tschöpe C; Adamson PB; Böhm M
    Clin Res Cardiol; 2018 Nov; 107(11):991-1002. PubMed ID: 29777373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic-Guided Heart Failure Management in Patients With Either Prior HF Hospitalization or Elevated Natriuretic Peptides.
    Desai AS; Maisel A; Mehra MR; Zile MR; Ducharme A; Paul S; Sears SF; Smart F; Bhatt K; Krim S; Henderson J; Johnson N; Adamson PB; Costanzo MR; Lindenfeld J;
    JACC Heart Fail; 2023 Jun; 11(6):691-698. PubMed ID: 37286262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care.
    Capomolla S; Febo O; Ceresa M; Caporotondi A; Guazzotti G; La Rovere M; Ferrari M; Lenta F; Baldin S; Vaccarini C; Gnemmi M; Pinna G; Maestri R; Abelli P; Verdirosi S; Cobelli F
    J Am Coll Cardiol; 2002 Oct; 40(7):1259-66. PubMed ID: 12383573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF Trial.
    Zile MR; Mehra MR; Ducharme A; Sears SF; Desai AS; Maisel A; Paul S; Smart F; Grafton G; Kumar S; Nossuli TO; Johnson N; Henderson J; Adamson PB; Costanzo MR; Lindenfeld J
    JACC Heart Fail; 2022 Dec; 10(12):931-944. PubMed ID: 36456066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remote Hemodynamic Monitoring Equally Reduces Heart Failure Hospitalizations in Women and Men in Clinical Practice: A Sex-Specific Analysis of the CardioMEMS Post-Approval Study.
    DeFilippis EM; Henderson J; Axsom KM; Costanzo MR; Adamson PB; Miller AB; Brett ME; Givertz MM
    Circ Heart Fail; 2021 Jun; 14(6):e007892. PubMed ID: 34129363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.
    Bourge RC; Abraham WT; Adamson PB; Aaron MF; Aranda JM; Magalski A; Zile MR; Smith AL; Smart FW; O'Shaughnessy MA; Jessup ML; Sparks B; Naftel DL; Stevenson LW;
    J Am Coll Cardiol; 2008 Mar; 51(11):1073-9. PubMed ID: 18342224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Implantable Hemodynamic Monitors to Manage Heart Failure.
    Abraham WT
    Cardiol Clin; 2017 May; 35(2):273-279. PubMed ID: 28411901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.